Exploiting the mutanome for tumor vaccination.

The findings provide a comprehensive picture of the mutanome of B16F10 melanoma and offer insight into the extent of the immunogenicity of nonsynonymous base substitution mutations, and argue that the use of deep sequencing to systematically analyze immunogenic mutations may pave the way for individualized immunotherapy of cancer patients.